Fusion Pharmaceuticals shareholders have overwhelmingly approved its ~$2B acquisition by AstraZeneca, expected to close by the end of Q2.

"BHP (NYSE:BHP) seeks an extension for talks with Anglo American (OTCQX:AAUKF) on its takeover proposal, citing proposed socioeconomic measures and the need for further engagement, with the deadline for merger talks looming."

Braavo Capital has closed a $5mn Series B funding round and a new $30mn debt fund to expand its Growth Ventures initiative focused on web monetization.

Merger and acquisition(M&A) volume is expected to rise 20% in 2024, rebounding from last year's contraction and nearing pre-pandemic activity levels, driven by significant increases in deal value and volume, particularly in technology, life sciences, and energy sectors.